Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present a range of research findings at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO ...

The Grafo movable acoustic whiteboard from Impact Acoustic offers flexibility of use. Acting as a collaboration tool or temporary separation in open-plan spaces while improving the acoustic ...

Dr. Pisano will continue to serve as study chair of the large-scale Tomosynthesis Mammographic Imaging Screening Trial (TMIST) for the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). TMIST is led ...

to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants. Adults with pulmonary arterial hypertension (PAH) have a new ...

The ECOG-ACRIN Cancer Research Group has enrolled the first patient in a new treatment trial to evaluate the effectiveness of adding nilotinib to standard paclitaxel chemotherapy.

Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810 ...

the ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center grant, the Mark Foundation for Cancer Research, ...

ComboMATCH is led by the ECOG-ACRIN Cancer Research Group and the NCI through the National Clinical Trials Network (NCTN). ComboMATCH treatment trials are conducted by the NCTN research groups in ...

The ECOG-ACRIN Cancer Research Group has enrolled the first patient in a new treatment trial to evaluate the effectiveness of adding nilotinib to standard paclitaxel chemotherapy. Prostate cancer ...

Dr. Sparano serves as Vice Chair of the ECOG-ACRIN Research Group and Vice Chair of the AIDS Malignancy Consortium. Jonas Teuwen is the Group Leader of AI for Oncology at the Netherlands Cancer ...